- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07225426
Personalizing Financial Incentives (Log2LoseAI)
March 5, 2026 updated by: Corrine Voils, University of Utah
Log2LoseAI: Reinforcement Learning to Create a Framework for Personalizing Financial Incentives
The purpose of this study is to determine the feasibility of providing personalized incentives for dietary self-monitoring and/or interim weight loss to people enrolled in a weight-loss program
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
In this study, community outpatients will participate in a clinician-facilitated, group-based behavioral weight-loss program for 24 weeks.
Dietary self-monitoring data (input by patients via a mobile phone dietary application) and weight data (input by patients via cellular scale) will be collected by a software platform.
A reinforcement learning algorithm will use data collected during the trial to predict which participants will respond to a financial incentive.
Incentives will be provided to participants predicted to respond, and they will be notified of incentives via text messaging.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Corrine Voils, PhD
- Phone Number: 801-585-6667
- Email: corrine.voils@hsc.utah.edu
Study Contact Backup
- Name: Fiona Robertson
- Email: fiona.robertson@hsc.utah.edu
Study Locations
-
-
Utah
-
Salt Lake City, Utah, United States, 84108
- Recruiting
- University of Utah
-
Contact:
- Corrine Voils, PhD
- Phone Number: 801-585-6667
- Email: corrine.voils@hsc.utah.edu
-
Contact:
- Fiona Robertson
- Email: fiona.robertson@hsc.utah.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Willing to attend virtual baseline and follow-up data collection visits
- At least 18 years of age
- Verified obesity as defined as a BMI ≥30 kg/m2
- Agree to attend 13 biweekly group classes (virtual) delivered by a registered dietitian
- Agree to review study materials between classes
- Regular access to an unshared smart phone
- Reliable access to internet
- Able to speak and read English
- Desire to lose weight
- Able to connect to a video conference call using a smartphone, tablet or computer with a webcam and microphone
- Ability to download and use Fitbit app daily
- Have or be willing to create a Gmail address
- Physical ability to stand on a scale without support
Exclusion Criteria:
- Weight loss of at least 10lbs in the month prior to screening
- Weight > 380lbs
- Currently enrolled or enrolled in the previous month in a clinical, research, or community program focusing on lifestyle change that could affect weight
- New user of weight loss medication
- Pregnant, lactating or planning on becoming pregnant during the study
- History of bariatric procedure or planning to have bariatric procedure in the study timeframe
- Residing in a nursing home, skilled nursing facility or assisted living facility
- Impaired hearing
- Significant dementia, drug or alcohol abuse, or unstable psychiatric illness (e.g., schizophrenia, psychosis)
- Current treatment for cancer or being treated for cancer (besides basal cell carcinoma or squamous cell) in the last 6 months
- Use of insulin, sulfonylureas, or meglitinides due to increased risk for hypoglycemia
- Diuretic medication doses higher than hydrochlorothiazide or chlorthalidone 25 mg daily, furosemide 40 mg daily, torsemide 20 mg daily, bumetanide 1 mg daily, or any use of metolazone; use of potassium-sparing diuretics is acceptable
- Unstable heart disease in the 6 months prior to screening
- Chronic kidney disease at stage 4 or higher
- Exertional chest pain
- Pain, fainting, or other conditions that prohibit mild/moderate exercise
- History of ascites requiring paracentesis
- Inducing vomiting to prevent weight gain or counteract the effects of eating an average of 1 time per week or more in the past 3 months*
- Not suitable for study participation due to other reasons at the discretion of the investigators
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Personalized incentives
Participants may receive financial incentives for weight loss if their performance suggests they respond to financial incentives.
|
Every week, a reinforcement learning algorithm will process data on weight loss, calorie logging, and incentives earned to predict that their weight loss is positively influenced by incentives.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Screening-to-enrollment ratio
Time Frame: Week 0
|
number of potential participants screened for the study/ number of participants who provide a baseline weight for the intervention
|
Week 0
|
|
Retention for outcomes
Time Frame: 25 weeks
|
number of participants who provide a weight at 25 weeks/number of participants who provide a baseline weight for the intervention
|
25 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to calorie logging
Time Frame: 24 weeks
|
Proportion of weeks participants achieve adequate calorie logging (5 days per week)
|
24 weeks
|
|
Adherence to self-weighing
Time Frame: 24 weeks
|
Proportion of weeks participants weigh at least twice per week on a study-provided cellular scale
|
24 weeks
|
|
Body weight
Time Frame: baseline to 25 weeks
|
Changes in body weight from baseline to week 25, measured by study-provided cellular scales
|
baseline to 25 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 4, 2026
Primary Completion (Estimated)
February 28, 2027
Study Completion (Estimated)
February 28, 2027
Study Registration Dates
First Submitted
November 4, 2025
First Submitted That Met QC Criteria
November 5, 2025
First Posted (Actual)
November 6, 2025
Study Record Updates
Last Update Posted (Actual)
March 6, 2026
Last Update Submitted That Met QC Criteria
March 5, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00188990
- R34HL170205 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
This study will collect weight data from the cellular-connect scales, calorie logging data from the dietary tracking app, and self-reported survey data including demographics and behavioral measures.
Additional data will include binary indicators for whether participants earned an incentive each week of the study and how much they earned, generated by algorithms created by the research team using scale and dietary tracking app data.
IPD Sharing Time Frame
Scientific data will be available by the earlier of these two time points, as required by the NIH: 1) the date on which the article is first made available in print or electronic format, or 2) the funding period (to include a possible no-cost extension).
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity & Overweight
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
Clinical Trials on personalized financial incentives
-
University of PennsylvaniaCompleted
-
The University of Hong KongUniversity Grants Committee, Hong KongCompletedDiabetes Mellitus, Type 2Hong Kong
-
University of PennsylvaniaCarnegie Mellon UniversityCompleted
-
VA Office of Research and DevelopmentNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
Brown UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedDiet, HealthyUnited States
-
NYU Langone HealthCompletedSmoking Cessation | Smoking, CigaretteUnited States
-
University of VermontNational Institute of General Medical Sciences (NIGMS)CompletedCoronary Artery DiseaseUnited States
-
University of PennsylvaniaWilliam and Flora Hewlett FoundationCompleted
-
Duke-NUS Graduate Medical SchoolSingapore General HospitalCompleted
-
University of Cape TownUniversity of Pennsylvania; Medical Research Council, South Africa; Carnegie... and other collaboratorsCompletedWellness Programs | Physical Activity BehaviorSouth Africa